Quantifying the duration of the preclinical detectable phase in cancer screening: a systematic review

OBJECTIVES: The aim of this study was to provide an overview of published mathematical estimation approaches to quantify the duration of the preclinical detectable phase (PCDP) using data from cancer screening programs. METHODS: A systematic search of PubMed and Embase was conducted for original stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Geurts, Sandra M. E., Aarts, Anne M. W. M., Verbeek, André L. M., Chen, Tony H. H., Broeders, Mireille J. M., Duffy, Stephen W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Epidemiology 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117108/
https://www.ncbi.nlm.nih.gov/pubmed/34990529
http://dx.doi.org/10.4178/epih.e2022008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117108/
https://www.ncbi.nlm.nih.gov/pubmed/34990529
http://dx.doi.org/10.4178/epih.e2022008

Ejemplares similares